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Ticks belong to the phylum Arthropoda, the class Arachnida, and the subclass Acari that 
includes mites and ticks (Sonenshine, 1991). There are 2 major families ofticks, i.e., the 
Ixodidae (hard ticks) and the Argasidae (soft ticks). The lone star tickAmblyomma 
americanum (L.) is a member of Ixodidae. Ticks are considered to be economically 
important because they are obligate blood sucking arthropods that infest every class of 
terrestrial vertebrates.including mammals and birds, various reptiles and even amphibians 
(Sonenshine, 1991). They transmit many pathogenic organisms including fungi, viruses, 
rickettsiae, bacteria, and protozoa and are among the most important vectors of human 
and animal diseases (Sonenshine, 1991). 
1 
The salivary glands are essential to the success of ticks in obtaining a bloodmeal. As 
feeding progresses, the rate of salivary secretion increases greatly, enabling the ixodid tick 
to concentrate the bloodmeal by returning excess water and ions to the host. Saliva in 
feeding ticks is rich in bioactive components that may facilitate prolonged feeding. 
Bioactive compounds identified in saliva or salivary glands include cement to help anchor 
the mouthparts to the host, anticoagulants, antihistamine, kininase, apyrase and 
prostaglandins (Sauer et al., 1995). Prostaglandins, mainly prostaglandin E2 (PGE2), have 
been identified in the saliva of four ixodid species (Sauer et al., 1993). 
2 
The prostaglandins are oxygenated derivatives of C20 fatty acids, mainly arachidonic acid 
(Coleman et al., 1990). Arachidonic acid is most often released from esterified stores in 
the plasma membrane by phospholipase A2 (PLA2) and can be converted into a series of 
compounds called eicosanoids through three major pathways, which include 
cyclooxygenase, lipoxygenase and cytochrome P-450 epoxygenase. The prostanoids are 
the products of the first of these to be discovered, the cyclooxygenase pathway, consisting 
· ofprostaglandins (PGE2, PGF2a, PGD2, PGh) and thromboxane A2 (TxA2). The 
lipoxygenase pathway produces the leukotrienes and certain mono-, di- and tri-hydroxy 
acids, and the cytochrome P-450 'epoxygenase' pathway forms the epoxides (Smith, 
1989). The scientific trail leading to the discovery of prostaglandins (PGs) can be traced 
back over 50 years to the observation by Kurzrok and Lieb (1930) that human semen can 
cause either uterine contraction or relaxation. The term "prostaglandin" was coined in 
1935 by von Euler (1935). After World War II, Bergstrom demonstrated that semen 
extracts contained a number of biologically active entities that were unusual in being non-
nitrogenous, hydroxylated fatty acids. Application of modern analytical, spectroscopic, 
and separation techniques in this field led to the elucidation of the prostaglandin structures 
and the biosynthetic pathways (Andersen et al., 1985). 
PROST ANO ID BIO SYNTHESIS 
Prostanoid biosynthesis has been studied extensively in normal and pathophysiological 
tissues and is well characterized (Fig. 1.1 ). It is now clear that prostanoids are not stored, 
but are synthesized de nova and released in response to a stimulus (Coleman et al., 1990). 
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Arachidonic acid is the most abundant of the prostanoid precursors and its metabolism via 
the cyclooxygenase pathway leads to formation of the 2-series prostanoids. The principal 
source of arachidonic acid for prostanoid formation is that esterified at the 2-acyl position 
in fatty acyl chains of glycerophospholipids. Prostanoid formation requires free, 
unesterified arachidonic acid. Once liberated, any arachidonic acid not metabolized to 
prostanoids or other eicosanoids is rapidly reesterified into a lipid by acyltransferase 
enzymes (Irvine, 1982). Prostaglandin endoperoxide synthase catalyzes the sequential 
formation of intermediates PGG2 and PGH2 (Needleman et al., 1986). The cyclooxygenase 
activity of this enzyme catalyzes the insertion of two molecules of oxygen into arachidonic 
acid to give the 15-hydroperoxy compound PGG2, and the peroxidase activity of the 
enzyme then reduces the hydroperoxy group to hydroxy, giving PGH2. The 
cyclooxygenase and peroxidase activities of endoperoxide synthase reside in a single 
protein. Formation of the primary prostanoids, PGE2, PGF2a, PGD2, PG!i and TxA2, is 
normally catalyzed by specific isomerases or reductases (Smith, 1992). According to Smith 
(1989), any given prostanoid-forming cell tends to form only one of these compounds as 
its major product. For example, smooth muscle cells and endothelial cells from large 
arteries form primarily PGI2 (DeWitt et al., 1983), platelets form mainly TxA2 (Hamberg 
et al., 1975), and PGE2 is the major product of collecting tubule cells in the kidney 
(Kirschenbaum et al., 1982). Prostanoids of the 2-series are formed by both vertebrates 
and invertebrates, but not by plants or bacteria which lack appropriate polyunsaturated C20 
fatty acid precursors (Smith, 1989). 
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In ticks, there are considerable data suggesting possible biosynthesis of prostanoids. 
Prostanoids have been identified in the saliva of at least four ixodid species (Higgs et al., 
1976; Dickenson et al., 1976; Shemesh et al., 1979; Ribeiro et al., 1985, 1988, 1992). 
Higgs et al. (1976) confirmed prostaglandin-like activity by bioassay (stimulation ofrat 
and chick smooth muscle preparation) in acid-lipid extracts of saliva from Boophilus 
microplus. Over 80% of the activity in the extracts had the same chromatographic 
mobility as PGE2 as assessed by thin layer chromatography. About the same time, 
researchers in Australia confirmed the existence of prostaglandin activity in the saliva of 
the same species of ixodid tick (Dickinson et al., 1976). Saliva from partially fed Ixodes 
dammini and A.americanum was demonstrated to contain PGE2, PGF2a and 6-keto-PGF1a 
(the stable degradation product ofprostacyclin) (Ribeiro et al., 1985, 1988; 1992). PGF 
and PGE2 were identified by radioimmunoassay (RIA) in the salivary glands as well as in 
reproductive organs and eggs of Hyalomma anatolicum excavatum (Shemesh et al., 
1979). Cultured salivary glands accumulated both PGF and PGE2 with increasing time of 
incubation suggesting an ability of the salivary glands to synthesize prostaglandins, at least 
when cultured in vitro. Shipley et al. ( 1993) found that salivary glands of A americanum 
female ticks contained relatively high levels of arachidonic acid, the precusor of 
prostanoids. Bowman et al.(1993) also demonstrated that PGE2, PGF2a and PGD2 existed 
with PGE2 at the highest concentration in secreted saliva of A. americanum following 
labelling of salivary glands in vivo with radiolabelled arachidonic acid. 
BIOLOGICAL ACTIONS OF PGE2 
5 
PGE2 is known to have a number of physiological and pathophysiological actions in 
diverse mammalian tissues. It can mediate contraction and relaxation of smooth muscle 
from various tissues (Coleman et al., 1990). It also exhibits both inhibition and 
enhancement of neurotransmitter release. PGE1 and PGE2 have been shown to cause 
inhibition of sympathetic neurotransmitter release in heart, vasculature, spleen, vas 
deferens and seminal vesicle of various species (Coleman et al., 1990). However, in the 
guinea pig ileum myenteric plexus preparation, E series prostanoids are found to enhance 
potently parasympathetic neurotransmission through an increase in the release of 
acetylcholine (Enrenpreis et al., 1973). In addition, PGE2 exerts a powerful modulating 
effect on human platelets, depending on the concentration of PGE2. At low concentration, 
PGE2 antagonizes the antiaggregatory action of PGE1 and PGI2 (Bonne et al., 1981). 
Higher concentration of PGE2 can inhibit platelet aggregation (Bruno et al., 1974). PGE2 
induces ovulation in rats and rabbits, and ovulation can be prevented by administration of 
indomethacin, an effect reversed by PGE2 administration (Lindner et al., 1980). PGE2 
modulates inflammatory (e.g. local vasodilatation, edema and pain) (Milton, 1976), and 
immune responses (e.g. inhibits both the function and proliferation of T cells) (Lewis, 
1983). The role of PGE2 in regulation of fluid transport is found in a wide range of 
organisms, including mammals, frogs, fishes, at least two mollusks, and insects (Stanley-
Samuelson and Pedibhotla, 1996). In the mammalian kidney, PGE2 regulates water and 
NaCl reabsorption in the collecting tubule and the adjacent thick ascending limb (Smith, 
1989). PGE2 has been shown to stimulate the rate of bone resorption induced by the 
parathyroid hormone (MacDonald, 1986). In rat gastric mucosa, PGE2 causes inhibition of 
gastric acid secretion in the parietal cell but stimulates gastric nonparietal secretion 
(Reeves and Stables, 1985; Major and Scholes, 1978; Soll, 1980; Wollin et al., 1979). In 
the amphibian cornea, both E and F prostaglandins stimulate er transport across the 
epithelium, and thus contribute to the maintenance of corneal transparency (Beitch et al., 
1974; Bentley and McGahen, 1982). Bjerregaard and Nielsen (1987) demonstrated that 
PGE2 stimulated an active secretion of er, Na\ and K+ from the skin glands in isolated 
skin of frog. In fish, PGE1 and E2 reduce ion effiux in seawater-adapted mullet and in the 
killfish (Brown et al., 1991). PGE2 also regulates ion and water transport in invertebrates. 
Freas and Grollman (1980) reported that PG synthesis increased in gill tissues of the 
marine bivalve Modiolus demissus during hypoosmotic stress. PGs regulate sodium 
transport in another bivalve, the freshwater mussel Ligumia subrostrata (Sanitsing and 
Dietz, 1983). In insects, PGE2 has been suggested to influence fluid secretion in 
Malpighian tubules (MTs) from females of the yellow fever mosquito, Aedes aegypti 
(Petzel and Stanley-Samuelson, 1992) and from workers of the forest ant, Formica 
polyctena (Van Kerkhove et al., 1995). Both of these studies report that eicosanoid 
biosynthesis inhibitors reduce basal fluid secretion rates in isolated MTs. 
PROSTANOID RECEPTORS 
6 
The presence of prostanoid receptors is at first inferred from the pharmacological 
properties of prostanoids. Prostanoids display high potency even at concentrations as low 
as 10-11 Mand small chemical modifications can have profound effects on their potency 
and profile of biological activity, and different prostanoids can have different effects on the 
same cell type (Coleman et al., 1990). Distinct receptors have been identified for each of 
the five naturally occurring prostanoids, PGE2, PGF2a., PGD2, PGii and TxA2 by using 
pharmacological comparisons of agonist and antagonist potency, and biochemical ligand-
binding studies, and analyzing PG-induced signal transduction in cells (Coleman et al., 
1990). These studies suggest that the prostanoid receptor is a receptor coupling via a G 
protein to effectors such as adenylate cyclase and phospholipase C. In the case of PGE2 
receptors, four subtypes have currently been identified, namely EPl, EP2, EP3, and EP4 
(Coleman et al., 1990, 1994). EPl subtype is coupled to Ca2+ mobilization, EP2 and EP4 
are coupled to stimulation of adenylate cyclase and EP3 is coupled to inhibition of 
adenylate cyclase (Negishi et al., 1995). These four PGE receptor subtypes have been 
cloned from various tissues (Sugimoto et al., 1992; Honda et al., 1993; Watabe et al., 
1993; Adam et al., 1994; Breyer et al., 1994; Nam.ha et al., 1994; Regan et al., 1994; 
Sando et al., 1994; Yang et al., 1994; Nishigaki et al., 1995). The molecular structures 
show that they contain seven hydrophobic segments corresponding to the putative 
transmembrane domains, suggesting that they belong to the family of G protein-coupled 
rhodopsin-type receptors (Negishi et al., 1995; Narumiya, 1996). 
SIGNAL TRANSDUCTION FOR PGE2 RECEPTORS 
Cells respond to external stimuli through transmembrane signaling that stimulates 
intracellular messenger pathways, such as the inositol 1,4,5-trisphosphate/Ca2+ signal, 
adenylate cyclase/cyclic adenosine 3',5'-monophosphate (cAMP), guanylate cyclase/cyclic 
guanosine 3',5'-monophosphate (cGMP), diacylglycerol/protein kinase C, voltage-
7 
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dependent and -independent Ca2+ channels, and growth factors /tyrosine kinase/tyrosine 
phosphatase (Tsunoda, 1993). These pathways are present in different cell types and 
impinge on each other for the modulation of the cell function. PGE2 can cause versatile 
and opposite action in various tissues and cells due to its receptor subtypes being coupled 
to a variety of signal transduction pathways (Fig.1.2). PGE2 is found to stimulate 
intracellular Ca2+ concentration increases in Chinese hamster ovary (CHO) cells expressing 
the mouse EPl receptor (Watabe et al., 1993), osteoblast cell line UMR-106 (Yamaguchi 
et al., 1988), MDCK cells (Aboolian et al, 1989) and Swiss 3T3 fibroblast cells 
(Yamashita and Takai, 1987). The mechanism of the increase in [Ca2+]i involves a Mn2+ -
insensitive Ca2+ channel, stimulation of phosphoinositide metabolism, and intracellular 
Ca2+ mobilization (Katoh et al., 1995; Negishi et al., 1995). The EPl receptor is 
associated with a pertussis toxin-insensitive G protein since guanine nucleotides promote 
the dissociation of PGE2 from EPl receptor (Negishi et al., 1995). It is also found that 
protein kinase C acts as a negative regulator ofEPl receptors. Protein kinase C induces 
both short-term and long-term desensitization ofEPl receptors (Negishi et al., 1995). 
PGE2 is demonstrated to stimulate adenylate cyclase activity in CHO cells expressing the 
mouse EP2 receptor (Honda et al., 1993). Guanine nucleotides can reduce the affinity of 
PGE2 binding to the EP2 receptor, suggesting that this receptor is coupled to Gs (Negishi 
et al., 1995). The EP4 receptor, like the EP2 receptor, is positively coupled to adenylate 
cyclase ( Coleman et al., 1994). PGE2 can strongly inhibit adenylate cyclase in CHO cells 
expressing the EP3 receptor, and this inhibition can be completely blocked by pertussis 
toxin (PT) treatment, indicating that EP3 is coupled to a PT-sensitive Gi protein 
(Sugimoto et al., 1992). It has also been found that PGE2 stimulates phosphoinositide 
metabolism and Ca2+ mobilization (Irie et al., 1994), suggesting that EP3 is coupled to 
multiple signal transduction systems. 
OBJECTIVES OF THIS STUDY 
Tick salivary glands serve as major osmoregulatory organs and are thus critical to the 
biological success ofticks during tick feeding. Understanding how salivary secretion is 
controlled becomes most important in clarifying the mechanism of secretion. Current 
knowledge about factors controlling salivary secretion is very limited. The best 
documented agonist ofsecretion is dopamine, a neurotransmitter released at the 
neuroeffector junction, to initiate salivary secretion (Sauer et al., 1995). Since dopamine 
can also stimulate the release of arachidonic acid from salivary gland phospholipids 
(Bowman et al., 1995a) which may then be metabolized into prostaglandins, can 
prostaglandins ( e.g. PGE2) function in regulation oftick salivary secretion in the same 
manner as in other tissues? For example, in the mammalian kidney, arginine vasopressin 
(A VP) induces the biosynthesis of PGE2 in the collecting tubule which regulates A VP-
induced water and sodium reabsorption in both the collecting tubule and the thick limb 
(Smith, 1989). The objectives of the present study were: 
1. To investigate whether PGE2 plays a role in regulating tick salivary secretion; 
2. To determine whether receptors for PGE2 exist in tick salivary glands; 
3. To study signal transduction pathways following interaction of PGE2 with its receptor 
in tick salivary glands. 
9 
Figure 1.1 Biosynthetic pathway for prostailoid formation. AA: arachidonic acid. 
















































Fig. 1.2 Signalling transduction utilized by three PGE2 receptor subtypes (EP 1, 
EP2 and EP3) in mammals. Gs and Gi, stimulatory and inhibitory G proteins, 
respectively; AC, adenylate cyclase; PLC, phopholipase C; DG, diglyceride; IP3, inositol 
1,4,5-trisphosphate; ER, endoplasmic reticulum; PIP2, phosphatidylinositol 4,5-
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CHAPTER2 
A ROLE OF PROSTAGLANDIN E2 IN MODULATING THE 
DOPAMINE-INDUCED SALIVARY SECRETION IN THE 
FEMALE TICK, AMBLYOMMA AMERICANUM (L.) 
INTRODUCTION 
12 
The salivary glands are the major osmoregulatory organs of ticks during tick feeding. It 
has been clearly shown that the ixodid tick salivary glands excrete excess fluid back to the 
host while the tick is attached and feeding (Gregson, 1967; Tatchell, 1967; Kaufinan and 
Phillips, 1973a; Sauer, 1977). Ingested blood is concentrated within the tick gut as excess 
ions and water from the blood meal are transported across the gut epithelium into the 
haemolymph and are secreted back into the host via the salivary glands (Tatchell, 1967, 
1969; Kirkland, 1971; Kaufinan and Phillips, 1973a, b, c; Meredith and Kaufinan, 1973; 
Sauer, 1977). Salivary gland fluid secretion is controlled by nerves (Kaufinan, 1979). 
Salivary glands of several species were observed to be innervated from microscopic 
studies (Fawcett et al., 1986) and catecholamines were found in nervous tissue and 
salivary glands using Falck-Hillarp fluorescence (Megaw and Robertson, 1974; Binnington 
and Stone, 1977). Dopamine is the predominant catecholamine in the salivary glands of A. 
hebraeum (Binnington and Stone, 1977; Kaufinan and Harris, 1983). The neurotransmitter 
dopamine induces fluid secretion when applied to isolated salivary glands (Kaufman 1976; 
Sauer et al., 1979) and when injected into the tick's haemocoel (Hsu and Sauer, 1975). 
13 
The molecular base for the action of dopamine is through an increase in intracellular levels 
of cAMP (Schmidt et al., 1982). 
It is interesting to note that dopamine also stimulates the release of arachidonic acid from 
phospholipids in the tick salivary glands by presumably activating an intracellular PLA2 
(Bowman et al., 1995a). Free arachidonic acid may be converted into PGs via the 
cyclooxygenase pathway in tick salivary glands (Higgs et al., 1976; Dickenson et al., 
1976; Shemesh et al., 1979; Ribeiro et al., 1985, 1988, 1992; Bowman et al., 1993; 
Shipley et al., 1993). The occurrence of PGs in tick salivary glands may indicate an 
autocrine role for these compounds in ticks. PGE2 has been shown to modulate fluid 
transport in a wide range of tissues both in vertebrates and invertebrates. In invertebrates, 
PGE2 is believed to regulate overall fluid secretion rates in insect Malpighian tubules 
(MTs) (Petzel and Stanley-Samuelson, 1992; Van Kerkhove et al. 1995). PGE1 was 
shown to inhibit 5-hydroxytryptamine stimulated fluid secretion in Calliphora 
erythrocephala salivary glands via an inhibitory effect on adenylate cyclase (Dalton, 
1977). It appears that regulation of ion and water transport is a fundamental eicosanoid 
action in animals (Stanley-Samuelson, 1994). The present work was undertaken to 
investigate whether PGE2 participates in regulation of overall fluid secretion in tick 
salivary glands. 
MATERIALS AND METHODS 
Materials 
14 
Reagents were obtained from the following sources: M-199 medium (Sigma catalogue#, 
M 0393), oleyloxyethyl phosphorylcholine, esculetin, clotrimazole, indomethacin, 
acetylsalicylic acid, diclofenac, PGE2, 17-phenyl trinor PGE2, and other chemicals were 
acquired from Sigma (St.Louis, MO). The cyclic AMP assay kit was obtained from 
Arnersham International plc (Arnersham, UK). PGF2a, PGD2 and U-46619 were from 
Cayman Chemical Co.(Ann Arbor, MI). 
Ticks 
Amblyomma americanum ticks were reared at Oklahoma State University's Central Tick 
Rearing Facility.according to the methods of Patrick and Hair (1975). Immature ticks 
were fed on rabbits and adult ticks on sheep. All unfed ticks were maintained at 27-28°C 
and 90% RH under a 14: 10 (L:D) photoperiod before infestation of the hosts. Partially fed 
female ticks weighing from 100 mg to 150 mg were removed by traction and immediately 
used for all the assays. 
Assay of Salivary Secretion 
Salivary glands were dissected and secretion was measured as described by Harris et.al. 
(1984) and McSwain et al. (1992). Briefly, the dorsal cuticle of a tick was carefully 
removed by making a circular lateral incision around the tick with a single-edge razor 
blade. M-199 buffer (pH 7.0) was then added to the tick haemocoel. The gut, 
reproductive, nervous and tracheal systems, along with any adhering tissues, were 
carefully removed to fully expose the salivary glands and ducts. The main duct was tied off 
15 
with a silk thread (size 4-0) (Ethicon, Inc.) and then carefully cut in front of the knot. For 
each pair of isolated glands, one was used for the treatment and the other as the control. 
In assays for examining the effects of various eicosanoid inhibitors on secretion, the 
isolated salivary glands were weighed and then incubated with the various eicosanoid 
synthesis inhibitors ( treatment gland) or solvent carrier ( control gland) for 15 min, 
followed by incubation for 5 min in 10 µM dopamine dissolved in the previous solutions. 
After incubation, the glands were rinsed in buffer for 3 min, weighed, and returned to the 
incubation solutions for another 5 min. The process was repeated. After each designated 
time interval, the glands were reweighed. The weight changes before and after treatment 
represent the secretory abilities of the isolated salivary glands. In examining the ability of 
PGE2 to reverse inhibition of secretion by inhibitors of PLA2 or cyclooxgenase, isolated 
salivary glands were pretreated with the inhibitor for 15 min by the same procedure as in 
the previous assays, followed by incubation in the same buffer containing 10 µM 
dopamine, 100 µM prostaglandin, and cAMP phosphodiesterase inhibitor, 10 mM 
theophylline or lmM 3-isobutyl-1-methyl-xanthine (IBMX). A control consisted of the 
same reaction mixture without prostaglandin. 
cAMP Assay 
Salivary glands were prepared as in the secretion assays. Glands were incubated in M-199 
buffer, pH 7.5, containing lmM IBMX plus the desired effectors (treatment) or solvent 
carriers (control) for 32 min. The reaction was terminated by placing glands in 100 µl of 
50 mM Tris(hydroxymethyl)aminomethane (Tris)/4 mM EDTA buffer, pH 7.5, on ice. 
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Levels of cAMP were measured with a cAMP kit by Amersham using the protein binding 
method according to the manufacturer's instructions. This method relies on the 
competition between [3H]-labelled cAMP and unlabelled cAMP in the sample for a cAMP-
binding protein. Free [3H]cAMP was adsorbed by charcoal and removed by centrifugation, 
and bound [3H]cAMP in the supernatant was determined by liquid scintillation counting. 
In this assay, the glands were homogenized by sonication for 30 sec, following by heating 
for 3 min in a boiling water bath to coagulate protein (piercing caps of the microfuge tubes 
with a syringe needle to prevent the caps from popping oft). After centrifugation at 
12000g for 5 min, the supernatant containing cAMP was used in the cAMP competitive 
binding assay. 50 µl of the supernatant, 50 µl of [3H]cAMP and 100 µl binding protein 
solution were mixed together and placed on ice for 2 hour. After incubation, 100 µl 
charcoal suspension was added to the reaction mixture, followed by centrifugation for 2 
min at 12000g at 4°C. Free [3H]cAMP was thus removed by charcoal and [3H]cAMP-
binding protein complex was in supernatant. The cAMP content of the unknown sample 
was determined by interpolation from a cAMP standard curve. 
Statistical Analysis 
The differences between the control and experimental treatment were tested for 
significance by paired Student's t test. AP value <O. 05 was considered significant. 
RESULTS 
The effects of eicosanoid synthesis inhibitors on dopamine induced secretion by salivary 
glands in vitro. 
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Various inhibitors of eicosanoid synthesis, including PLA2 inhibitors oleyloxyethyl 
phosphorylcholine (OPC) and dexamethasone (DEX), the arachidonic acid analogue 
eicosatetraynoic acid (ETYA), the inhibitor of PLA2, cyclo-oxygenase and lipoxygenase, 
lipoxygenase inhibitor esculetin (ESC) and cytochrome P-450 inhibitor 
clotrimazole(CTM) as well as cyclo-oxygenase inhibitors indomethacin (INDO), 
acetylsalicylic acid (ASA), and diclofenac (DIC), were tested and examined for their 
effects on secretion induced by dopamine in isolated salivary glands. Dopamine is known 
to stimulate release of arachidonic acid in isolated salivary glands (Bowman et al., 1995) 
and arachidonic acid may be metabolized under these conditions to prostaglandins. The 
results showed that treatment of isolated salivary glands with PLA2 inhibitor OPC or 
cyclo-oxygenase inhibitor ASA at 10 µM inhibited dopamine-stimulated secretion (Fig. 
2.1 ). An inhibitor oflipoxygenase, ESC, at 100 µM and an inhibitor of cytochrome P-450, 
CTM, at 10 µM had no significant effect on dopamine stimulated secretion (Fig. 2.1 ). The 
inhibition of in vitro salivary secretion by OPC, ASA or DIC was dose dependent (Fig. 
2.2, 2.3). Other eicosanoid biosynthesis inhibitors ETY A, DEX and INDO also blocked 
dopamine-stimulated secretion at certain concentrations (Table 2.1 ). The results suggest 
that cyclo-oxygenase products may be synthesized and play an important role in enhancing 
dopamine-stimulated salivary secretion. 
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Reversal by PGE2 of the inhibition of dopamine-stimulated salivary secretion by inhibitors 
of PLA2 and cyclo-oxygenase 
Isolated salivary glands in the presence of 1 mM OPC treated with 100 µM PGE2 or its 
analog 17-phenyl trinor PGE2 increased secretion above the level observed in glands in 
OPC alone (Fig. 2.4). However, neither 100 µM PGE2 nor its analog 17-phenyl trinor 
PGE2 stimulated secretion above that noted when secretion was inhibited by cyclo-
oxygenase inhibitors indomethacin, ASA, and diclofenac. PGE2 was unable to stimulate 
secretion at low concentrations. PGF2a (100 µM) was ineffective in stimulating secretion 
inhibited by OPC (Fig.2.4). Arachidonic acid was unable to recover the secretion inhibited 
by 1 mM OPC ( data not shown). In the absence of dopamine, PGE2 had no effect on 
salivary secretion ( data not shown). 
The effects of inhibitors of PLA2 and cyclo-oxygenase, and PGE2 on intracellular cAMP 
accumulation 
Since dopamine stimulates salivary secretion through an increase in cAMP (Schmidt et al., 
1982), the effect of PGE2 on regulation of the fluid secretion stimulated by dopamine was 
examined by investigating the role of PGE2 in cAMP metabolism. The PLA2 inhibitor OPC 
at 1 mM inhibited dopamine-stimulated cAMP accumulation about 25%. In addition, the 
cyclo-oxygenase inhibitor indomethacin at 1 mM inhibited cAMP accumulation about 
27%. Verapamil, which inhibits dopamine-stimulated secretion by blocking Ca2+ influx 
(Needham et al., 1979) and also blocks arachidonic acid release (Bowman et al., 1995a), 
also reduced the cAMP accumulation about 65% at 1 mM (Table 2.2). In the presence of 
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OPC, PGE2 and its analog 17-phenyl trinor PGE2 stimulated cAMP accumulation about 
20% and 40% above the OPC inhibited control, respectively (Fig. 2.4). However, neither 
PGE2 nor its analog 17-phenyl trinor PGE2 stimulated cAMP accumulation above that 
inhibited by cyclo-oxygenase inhibitor indomethacin, or verapamil. PGF2a. did not 
stimulate an accumulation of cAMP above that observed in the presence of 1 mM OPC 
(data not shown). As for secretion, PGE2 on its own had no effect on cAMP 
accumulation. 
DISCUSSION 
Eicosanoids are oxygenated derivatives of C20 fatty acids, mainly arachidonic acid. 
Arachidonic acid is released from phopholipids after stimulation of tick salivary glands by 
dopamine (Bowman et al., 1995a). Treatment of isolated salivary glands with inhibitors of 
eicosanoid biosynthesis OPC, ETY A, and DEX, significantly reduced dopamine-induced 
fluid secretion, suggesting a role for eicosanoids in regulating secretion. In order to probe 
specific products that participate in regulation of the fluid secretion, pharmaceutical 
inhibitors of the specific pathways were used in the secretion assays. Inhibition of 
cyclooxygenase by ASA, INDO, and DIC resulted in reduced fluid secretion. However, an 
inhibitor oflipoxygenase (ESC) or cytochrome P-450 (CTM) appeared to have no effect 
on regulation of salivary secretion. Furthermore, PGE2 or its analog 17-phenyl trinor PGE2 
was able to partially reverse the secretion inhibited by OPC. Our results suggest a role for 
PGE2 in regulating tick salivary secretion. Additional evidence in support of this 
hypothesis comes from the experiments showing the effects of eicosanoid biosynthesis 
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inhibitors and PGE2 on cAMP formation in tick salivary glands. Both the PLA2 inhibitor 
OPC or verapamil and the cyclooxygenase inhibitor INDO reduced dopamine-stimulated 
cAMP accumulation. Either PGE2 or its analog 17-phenyl trinor PGE2 increased cAMP 
accumulation above the OPC inhibited control, respectively. In addition, the increase of 
cAMP accumulation by PGE2 or 17-phenyl trinor PGE2 is about the same as the increase 
of salivary secretion (Fig. 2.4). cAMP is known to be a "second messenger" molecule in 
the regulation of salivary fluid secretion in ixodid females (Sauer et al., 1976; 1979). 
Levels of cAMP increase when isolated salivary glands are stimulated by dopamine (Sauer 
et al., 1979). Exogenous cAMP stimulates glands, in vitro, to secrete fluid (Sauer et al., 
1984) and a phophodiesterase inhibitor, theophylline, augments secretion stimulated by 
low levels of dopamine (Sauer et al., 1979). The stimulatory effect of cAMP is also 
enhanced by theophylline (Sauer et al., 1979). The specificity of cAMP action resides with 
various endogenous substrate proteins which are phosphorylated by cAMP-dependent 
protein kinase which facilitate the fluid secretory process (Greengard, 1978). The present 
findings suggest that PGE2 may be involved in regulating salivary secretion by affecting 
salivary gland levels of cAMP. 
However, the results have certain ambiguities. Although a variety of cyclo-oxygenase 
inhibitors decrease dopamine-stimulated secretion and at least one (indomethacin) inhibits 
dopamine-stimulated accumulation of cAMP, their effects cannot be reversed by PGE2. 
Why this is so for inhibitors of cyclo-oxygenase but not an inhibitor of PLA2 (OPC) is 
unclear. In addition, neither PGE2 nor its analog 17-phenyl trinor PGE2 stimulates salivary 
secretion and intracellular cAMP formation on its own. Overall, the action of PGE2 in 
salivary gland physiology seems to be related to events after salivary glands are first 
stimulated by dopamine and the magnitude of effects is modest. 
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Table 2.1 Inhibition of salivary secretion by eicosanoid biosynthesis inhibitors. Values 
represent percentage inhibition of secretion as compared to the control after the isolated 
salivary glands were incubated in the following pharmaceutical treatments for 16 min. 
Each value is the meari ± SE. * Significantly different from the control (P<0.05). PLA2: 











Concentration %Inhibition Number 
(M) in secretion 
I0-4 39;9± 13.9* 4 
IQ-5 17.8 ± 8.2* 16 
IQ-3 93.2 ± 5.7* 7 
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Table 2.2 Inhibition of intracellular cAMP formation by inhibitors (lmM) of PLA2 or 
cyclooxygenase. ·Values represent percentage inhibition of cAMP formation as compared 
to controls after the isolated salivary glands were treated with reagents for 32 min. Each 
value is the mean± SE. * Significantly different from the control(P<0.05). PLA2: 
phospholipase A2; COX: cyclooxygenase. 
Treatment Target % Inhibition Number 
in cAMP 
OPC ,~J>LA2-- 25.2 ± 9.5* 12 __ ,,, --"""""-" .... ,... .. ,.,.__..,_,.,.,.._._..,...,," .... .,._..,.,..,.,. .. _~ .. .,..~ 
INDO cox 26.6 ± 6.9* 10 
Figure 2. I Comparison of the effects of various eicosanoid synthesis inhibitors on 
secretion by isolated salivary glands after 32 min. The control glands were treated with 
dopamine (10 µM) alone. The experimental glands were treated with dopamine (10 µM) 
plus the inhibitors as indicated. PLA2 inhibitor OPC and cyclo-oxygenase inhibitor ASA 
significantly inhibited secretion about 40% and 33% respectively(*: P<0.05). However, 
no significant difference was observed using cytochrome P-450 inhibitor CTM, or 
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Figure 2.2 Inhibition of in vitro salivary secretion by different concentrations of (A) 
PLA2 inhibitor oleyloxyethyl phosphorylcholine (OPC) and (B) cyclo-oxygenase 
inhibitor aspirin (ASA) (te3). The experimental glands were treated with dopamine ( 10 
µM) plus the inhibitors as indicated. The control glands were treated with dopamine (IO 
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Figure 2.3 Inhibition of in vitro salivary secretion by different concentrations of 
cyclo-oxygenase inhibitor diclofenac. The experimental glands were treated with 
dopamine ( 10 µM) plus the inhibitor at the indicated concentrations for 15 min. The 
control glands were treated with dopamine (10 µM) plus the solvent carrier (3% DMSO) 
of the inhibitor for the same incubation time as the experimental glands. * Significantly 
different from control (P<0.05). 
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Diclof enac (M) 
n=6 
n=6 
Figure 2.4 The effects of 100 µM prostaglandins on secretion and.intracellular cAMP 
formation in isolated salivary glands. In secretion assays, the control glands were treated 
with OPC (1 mM) plus dopamine (10 µM) and the prostaglandin solvent carrier (ETOH) 
for 16 min. In cAMP assays, the incubation mixtures contained the phosphodiesterase 
inhibitor theophylline (10 mM) or IBMX (1 mM) in addition to the same components as 
in the secretion assays(*: P<0.05). 
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CHAPTER3 
CHARACTERIZATION OF A SPECIFIC PROSTAGLANDIN E2 
RECEPTOR IN THE SALIVARY GLANDS OF THE FEMALE 
TICK, AMBLYOMMA AMERICANUM (L.) 
INTRODUCTION 
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Prostanoids are thought of as local hormones functioning to co-ordinate effects of those 
other hormones which induce eicosanoid synthesis in vertebrates (Smith, 1989). Following 
their intracellular synthesis, prostanoids exit the cell, probably via facilitated diffusion 
(Smith, 1986; Lam et al., 1990). After exiting the cell, prostanoids act on the parent cell 
and /or neighboring cells in an autocrine and /or paracrine fashion through specific G 
protein-linked prostanoid receptors to stimulate or inhibit changes in the levels of second 
messengers (Smith, 1992). PGE-specific binding sites have been identified in the plasma 
membranes of various tissues that have a potential receptor function, including adipocytes, 
corpora lutea, myometrium, kidney, intestinal epithelium, liver, heart, brain, gastric 
mucosa, erythrocytes, circulating immune cells and platelets (Robertson, 1986; Beinborn 
et al., 1988; Coleman et al., 1990; Virgolini et al., 1992; Hamon et al., 1993). The 
function of PGs in regulation of fluid transport has been mostly studied in vertebrates, 
for example, in the mammalian kidney (Smith 1989; Frazier et al. 1992). Low 
concentrations ofPGE2 (:s;l0·8M) are found to inhibit arginine vasopressin (AVP)-induced 
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water and sodium reabsorption by interfering with A VP-induced cyclic AMP synthesis on 
the collecting tubule and thick ascending limb. However, higher concentrations of PGE2 
(;?:10·7M) cause stimulation of water reabsorption by activating adenylate cyclase in both 
collecting tubule and thick limb cells (Smith, 1989). The opposite actions of PGE2 are 
considered to result from the existence of both stimulatory and inhibitory PGE2 receptor 
subtypes in the kidney (Watanabe et al., 1986). Recently, Sugimoto et al (1994) 
demonstrated that a high level ofEPl receptor mRNA was expressed in the collecting 
ducts of the kidney where PGE2 attenuated the vasopressin-induced osmotic water 
permeability through Ca2+ mobilization. The EPl receptor is therefore thought to be an 
important modulator of renal function through opening Ca2+ channels in plasma 
membranes. 
Although there are many reports of physiological effects of prostaglandins in invertebrates, 
there is little evidence of prostaglandin receptors. An exception is a receptor of a 
prostaglandin A2 iri the gill tissue of a marine bivalve Modiolus demissus (Freas and 
Grollman, 1981 ). Since PGE2 has been found to play a role in modulating tick salivary 
secretion, it is possible that the binding of PGE2 to a specific receptor may be the initial 
step leading to its physiological action on the tissue. Therefore, the present work was 
undertaken to examine if prostaglandin receptors exist in tick salivary gland and 
characterize the receptors. 
MATERIALS AND METHODS 
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Materials 
Reagents were obtained from the following sources: PGE2, GTP, GDP, ATP, App(NH)p, 
dithiothreitol, cholera toxin, pertussis toxin, NAD, GTPyS, polyethylenimine and other 
chemicals were acquired from Sigma (St.Louis, MO). [5,6,8,11,12,14,15-3H(N)]- PGE2 
(171 Ci/mmol) was from Du Pont New England Nuclear (Boston, MA); PGF2a., PGD2 and 
U-46619 were from Cayman Chemical Co.( Ann Arbor, MI); GF/ F microglass 
filters(25mm) were from Fisher (St. Louis, MO); Filter-count was from Packard 
Instrument Company, Inc. (Downers Grove, IL); Thin-layer chromatography plates 20x20 
cm, 250 µm thickness channelled silica gel G with a preabsorbent zone were obtained 
from Analtech (Newark, DE). 
Preparation of Membranes 
Salivary gland membrane fractions were prepared according to Watanabe et al. (1986) and 
McSwain et al. (1987) with modifications. Briefly, salivary glands were dissected at 4°C in 
a solution of 50 mM Tris-HCl, 100 µM indomethacin, 2 mM EDTA, pH 7.5. The excised 
glands were homogenized in an all-glass homogenizer. The crude homogenate was 
centrifuged at 325 g for 5 min at 4°C. The supernatant was then centrifuged at 11500 g 
for IO min at 4 °C. The resulting pellet was resuspended in the dissection buffer and 
membranes collected by centrifugation at 11500 g for 10 min twice more. The washed 
membrane pellet was resuspended in the dissection buffer for use in PGE2 binding assays. 
If membrane preparations were not used immediately, they were stored at -70°C. Protein 
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was determined by the Bio-Rad Protein Assay (Bio-Rad Laboratories) using bovine serum 
albumin as a standard. 
Gradient Purification of Plasma Membranes 
Gland membrane fractions were further purified by sucrose gradient centrifugation in 
experiments when effects of guanine nucleotides and exotoxins on the PGE2 binding 
activity were investigated. Membranes prepared as above were suspended at a protein 
concentration of 2-5 mg/ml in 50 mM Tris-HCl, 2 mM EDTA, pH 7.5, containing 1.95 M 
sucrose. The suspension was overlayed with 0.25 M sucrose and the sample centrifuged at 
100,000 g for 60 min at 4°C. Material at the interface of 0.25 Mand 1.95 M sucrose was 
withdrawn with a syringe, diluted with about 5 volumes of 50 mM Tris-HCl, 2 mM 
EDT A, pH 7. 5 and centrifuged at 100,000 g for 60 min at 4 °C. The pellet was washed 
twice with 50 mM Tris-HCl, 2 mM EDTA, pH 7.5, and suspended in 50 mM Tris-HCl, 2 
mM EDT A, pH 7. 5. Purified membrane preparations were stored at -70°C until use. 
Binding Assays 
Direct binding assays of PGE2 to the plasma membrane fraction were performed with 
[3H]-lablelled PGE2 according to Williams and Sills (1990) with some modifications. The 
principle of this assay is that receptor-ligand (RL) complexes are formed by the incubation 
of membranes together with radiolabelled PGE2. Once the RL complexes are formed, the 
unbound radioactivity can be removed by filtration through microglass filters. After 
filtration, the radioactivity associated with the microglass filters is quantified by liquid 
scintillation counting. Since radioactivity can also be associated with sites that are not 
related to the receptor, a parallel assay with an excess of unlabeled PGE2 is included to 
measure nonspecific binding. Measurement of binding in the absence and presence of 
unlabeled PGE2 provides data on total ligand binding and nonspecific binding, 
respectively. Their difference is the specific binding of PGE2. 
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The PGE2 binding assays used the standard assay mixture containing 50 mM Tris-HCI, 
3.84 mM MgCb, pH 7.5, 3 nM [3H] PGE2 and 50 µg membrane protein in a final volume 
of 200 µl. Some variations are indicated in the figure legends. Incubations proceeded for 3 
hours at 3 0°C and were stopped by the addition of 5 ml of ice-cold binding assay buffer 
and the solution filtered rapidly through a Whatman GF/F microglass filter under high 
vaccum. 20 glassfilters were soaked in a 2 ml of Tris solution at pH 9.1, containing 0.3% 
polyethylenimine (PEI) for 1-4 hr before use (Bruns et al., 1983). Pretreatment of 
glassfilters with PEI was used to reduce non-specific binding of radioligands to the surface 
of the glassfilters. Each filter was washed three times with 5 ml of ice cold buffer. In all 
experiments control assays were performed in parallel with 100 µM PGE2 included in the 
assay mixture to determine non-specific binding. 
PGE2 Metabolism 
The possibility that [3H]PGE2 might be degraded during the the binding assay was 
examined according to Bowman et al.(I995b ). After incubation, the assay suspension (200 
µl) was acidified by the addition of 800 µl H20 that has pH 3-5 adjusted with 3% formic 
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acid and lipids were extracted into 3 ml ethyl acetate (vigorous vortex for 90 sec). The 
phases were separated by centrifuging for 5 min at 2500 g. The upper organic layer was 
collected and the aqueous phase reextracted as before. The pooled lipid extract was dried 
under nitrogen and mixed with 3.5 µl standard cold PGE2 and 15 µ1 ethyl acetate.The 
control consisted of O. 5 µl [3H]PGE2, 3. 5 µl standard cold PGE2 and 15 µl ethyl acetate. 
They were applied to prewashed and activated silica gel G plates with preabsorbent zones. 
The plates were developed in a solvent system of chloroform-methanol-acetic acid-water 
(90: 8: 1: 0.8, v/v/v/v) (Salmon and Flower, 1982) in equilibrated developing tanks. The 
position of PGE2 was determined following exposure to iodine vapor in a tank. 
Distribution of the radioactivity was assessed by radioscanning (Bio Scan 2000, Bio Scan, 
Washington, DC). 
Treatment of Gland Membranes with Pertussis toxin or Cholera Toxin 
Purified membranes were treated with the exotoxins as described by Watanabe et al. 
(1986) and McKenzie (1992) with modifications. The membranes were incubated with 10 
µg of activated pertussis toxin at 3 0°C for 40 min in O. 5 ml of a mixture containing 100 
mM potassium phosphate, 5 mM MgCh, pH 7.5, 10 mM NAD, 1 mM ATP, 1 mM 
EGTA, 10 mM thymidine, 2 mM dithiothreitol, 100 µM GTP, 3 mM potassium 
phosphoenolpyruvate and 10 µg/ml of pyruvate kinase. For cholera toxin treatments, 
membranes were incubated with 100 µg of activated cholera toxin in the same medium as 
used for the pertussis toxin treatment. Controls were performed without treatment with 
toxins. Treated membranes were incubated with 10 mM N-ethylmaleimide at 0°C for 30 
min. Finally, the treated membranes were washed twice with 50 mM Tris-HCl, pH 7.5, 
containing 2 mM EDTA and suspended in binding assay buffer. Binding of 3 nM 
[ 3H]PGE2 was then measured in the presence and absence of 1 mM GTPyS. 
Statistical Analysis 
The differences between the control and experimental treatment were tested for 
significance by paired Student's t test. AP value <0.05 was considered significant. 
RESULTS 
Evidence of a Specific PGE2 Receptor in Tick Salivary Gland Plasma Membranes 
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To see whether the effects of PGE2 on secretion and level of cAMP are physiological, I 
sought evidence of a receptor in the salivary glands through the use of binding assays with 
[3H]-labelled PGE2. Thin layer chromatographic analysis indicated no significant 
metabolism of [3H]PGE2 during the incubation period for up to 12 hours at 30°C or 6 
hours at 37°C (Fig. 3.1). Almost half of PGE2 was metabolized into PGA2 during 
incubation for 10 hours at 37°C. 
Comparison of specific binding of PGE2 to different fractions of the salivary glands, i.e. 
11500 g pellet, 100,000 g supernatant and pellet, found that specific binding of PGE2 to 
the 11500 g fraction was at least three times that in other tissue fractions (Fig. 3.2). This 
fraction is known to contain the highest percentage of plasma membranes after tissue 
fractionation (McSwain et al., 1987). Electron micrographs of this fraction also showed 
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rich contents of membrane (Fig. 3.3). The 11500 g membrane fraction was therefore used 
in most of the subsequent binding assays. 
Specific binding of [3H]PGE2 to the 11500 g membrane fraction was directly related to 
membrane protein up to 200 µg (Fig. 3 .4). The specific binding of [3H]PGE2 to salivary 
gland membranes was also related to increasing concentrations of [3H]PGE2 (Fig. 3. 5). 
The optimum pH for the [3H]PGE2 binding was 8.5 (Fig. 3.6). In addition, the specific 
PGE2 binding activity was enhanced twice by 300 mM MgCh as compared to the binding 
activity in the presence of 3. 84 mM MgCh in the assay buffer. 
The specificity of [3H]PGE2 binding was investigated by adding increasing concentrations 
of various unlabelled prostaglandins (PGE2, PGF2a, PGD2 and TxA2) to the assay mixture. 
[3H]PGE2was displaced in the rank order ofPGE2> PGF2a.> PGD2> U-46619 
(nonhydrolyzableTxA2 analog) (Fig. 3. 7). The binding characteristic of [3H]PGE2 to the 
gland membranes was analyzed by a Scatchard plot of PGE2 displacement data using 
, LIGAND program (Munson et al., 1980). The best fit of the data indicated a single site 
model with a K~ 29 nM and Bmax~ 1.2 pmoles /mg protein. 
The time course of specific binding of [3H]PGE2 to membranes was studied at various 
temperatures (Fig. 3.8 A). The rate of specific binding of [3H]PGE2to membranes 
increased with increasing temperatures and reached equilibrium after 4 hr at 3 7°C and 6 hr 
at 30°C. Subsequent displacement experiments were carried out at 37°C. 100 µM 
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unlabelled PGE2 was added after [3H]PGE2 had incubated with membranes in assay tubes 
for 4 hr. Bound [3H]PGE2 was rapidly dissociated from the membrane fraction during the 
first 30 min and then the rate of dissociation slowed (Fig. 3.8 B). It is unclear why the 
bound labelled PGE2 was only partially displaced from membranes. 
Evidence that the PGEz.. Receptor is Associated with a Guanine Nucleotide Regulatory 
Protein 
A series of purine nucleotides was chosen to detect their effects on [3H]PGE2 binding 
activity. Data showed that both GTP and its nonhydrolyzable analog GTPyS significantly 
reduced specific [3H]PGE2 binding to gland membranes (Fig. 3.9 A). In constrast, ATP 
and GDP had no significant effects on the binding activity. ATPyS slightly reduced 
[3H]PGE2 binding activity. Moreover, 1 mM GTPyS reduced specific [3H]PGE2 binding to 
membranes in a PGE2 dose-dependent manner (Fig. 3.9 B). Results indicate that [3H]PGE2 
binding to membranes is sensitive to GTP. In order to confirm if the PGE2 binding activity 
is associated with a guanine nucleotide regulatory protein, I made another observation. 
Pretreatment of gland membranes with cholera toxin and NAD prevented GTPyS from 
inhibiting PGE2 binding activity (Table 3 .1 ). A similar treatment of membranes with 
pertussis toxin and NAD had no effect on the ability of GTPyS to inhibit PGE2 binding 
activity. These results strongly suggest that the PGE2 receptor in tick salivary glands is 
linked to a Gs-like rather than a GHike GTP-binding protein. 
DISCUSSION 
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[3H]PGE2 binding assays were performed to determine if a specific PGE2 receptor exists in 
tick salivary glands. The Scatchard analysis reveals a single PGE2 binding site with high a 
affinity (KD~ 29 nM) in tick salivary gland plasma membranes. Time courses of [3H]PGE2 
binding appear to be partially reversible. The incomplete reversibility of binding was also 
observed by several authors (Schillinger and Prior, 1976; Carsten and Miller, 1981; 
Sonnenburg et al., 1990; Hamon et al., 1993). Hamon et al.(1993) proposed that the 
incomplete dissociation could have resulted from an alteration of the binding sites or the 
ligand during the relatively long incubation ( covalent binding of the ligand could not be 
ruled out). Competition studies with different PGs show that PGE2 is the most effective in 
inhibiting the binding of [3H]PGE2 to the gland membranes, while PGF 2a and PGD2 are 
10-fold and 90-fold less effective respectively; TxA2 nonhydrolyzable analog U-46619 is 
least effective. The result indicates that the receptor site is specific for PGE2. 
The observation that PGE2 binding to gland membranes is reduced by GTP and its analog 
(GTPyS) indicates that the PGE2 receptor is functionally associated with a guanine 
nucleotide regulatory protein. In general, G protein-coupled receptors exist in two main 
conformational states, receptor alone having a low affinity for agonists and receptor 
coupled to the G protein having a high affinity (Graeser and Neubig, 1992). Binding of 
GTP to a G protein causes dissociation of the G protein from the receptor and thus 
decreases the affinity of the receptor. GTP-mediated decreases in affinity have been 
viewed as one of the key processes, along with the covalent receptor modification and G 
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protein GTPase activity, involved in preventing persistent cellular responses to hormones 
(Bimbaumer et al., 1985; Sibley and Lefkowitz, 1985). 
Further evidence shows that it is a cholera toxin-sensitive G protein because pretreatment 
of membranes with cholera toxin plus NAD eliminated GTPyS inhibition of PGE2 binding 
activity but pertussis toxin did not. Both toxins are bacterial exotoxins which catalyze the 
ADP-ribosylation of a specific G protein by NAD\ thereby uncoupling the G-protein from 
its receptor. To our knowledge, this is the first evidence of a PGE2 receptor coupled to a 
cholera toxin-sensitive G protein existing in an invertebrate. 
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Table 3.1 Effects of cholera toxin and pertussis toxin treatments on the inhibition by 
GTPyS of PG~ binding to tick gland membrane preparations. Salivary gland membranes 
were prepared and subjected to the indicated treatments and carried out in triplicate for 
[3H]PGE2 binding assays in the presence or absence of 1 mM GTPyS. This experiment 
was performed twice with similar results. *Values were significantly different from 
values in the absence ofGTPyS(P<0.05) 
Specific PG~ Binding (finoles/mg protein) 
Treatment 
-GTPyS +GTPyS 
Control 70±15 39±8* 
Pertussis toxin 82±14 38±7* 
Cholera toxin 51±13 50±20 
Figure 3.1 Radio-chromatogram of TLC separated ethyl acetate extracted products. 
(A) Standard sample (stock [3H]PGE2), with a stated purity of 97%; (B) Sample from 
incubation of [3H]PGE2 with gland membrane fractions for 12 hr at 30°C, about 97% of 
radioactivity co-chromatographed with authentic PGE2; (C) Sample from incubation of 
[3H]PGE2 with gland membrane fractions for 6 hr at 37°C, about 90% of the radioactivity 
co-chromatographed with authentic PG~. 
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Figure 3.2 Comparison of specific [3H]PG:Ei binding to different fractions of tick 
salivary gland homogenates. [3H]PGEi binding assays were performed at 24°C for 3 hr 
using 2.75 nM [3H]PGE2 and 128 µg protein (n>4); * indicates the values significantly 












Figure 3.3 Electron micrograph of the 11,500g pellet from the salivary gland 
homogenate of the female tick A. americanum taken by Dr. Katherine Kocan. Isolated 
membranes were pelleted in 1. 5 µm microcentrifuge tubes and fixed in 2% glutaraldehyde 
in a 0.2 M sodium cacodylate buffer overnight and postfixed in 2% osmium tetroxide in 
0.2 M sodium cacodylate buffer for 1 hr. The membranes pellet then dehydrated through 
a graded series of ethanol and infiltrated and embedded in epoxy resin (Dow Epoxy Resin 
732), using propylene oxide as the intermediate solvent. Thick sections (1.5 µm) were 
stained with Mallory's stain (Richardson etal., 1960) for 2 min at 60°C and were 
examined by light ·microscopy. Ultrathin (silver-gold reflective) sections were cut with a 
ultramicrotome (MT 7000, Research and Manufacturing Company, Inc.) and a diamond 
knife. Sections were collected on 300-mesh copper grids, stained with uranyl acetate and 
lead citrate (Venable and Coggeshall 1965), and observed and photographed with a 
transmission electron microscope (JEOL CX 100, JOEL Inc., Boston, MA) operated at 
80 kV. An abundance of membranes (Mb) and a few mitochondria (Mt) were seen in the 






Figure 3.4 Specific binding of [3H]PGE2 to tick salivary gland membranes as a 
function of membrane protein. The [3H]PGEi binding assay was performed in duplicate 
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Figure3.5 Specific binding of [3H]PGE2 to tick gland membranes as a function of 
concentrations of[3H]PGE2. The [3H]PGE2 binding assay was performed in duplicate for 
3 hr at 24°C using 140 µg membrane protein with the indicated concentrations of 
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Figure 3. 6 Specific binding of [3H]PG:Ei to tick salivary gland membranes at various 
pH. [3H]PGE2 binding assays were performed for 3 hr at 24 °C using 3 nM [3H]PGEi and 
























Figure 3.7 Inhibition of specific [3H]PG:Ei binding to gland membranes by various 
prostaglandins. The binding assays were performed in triplicate using 3 nM [3H]PG:Ei 
and 50 µg of membrane protein for 3 hr at 24°C (the assays used pH 8.5 and 300 mM 
MgCli) in the presence of the indicated concentrations·of prostaglandins. Displacement 
curves were fitted using SigmaPlot (Jandel) and the IC50 values were determined as the 
concentration of prostaglandins necessary to cause 50% inhibition of binding of 3 nM 
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Figure3.8 (A) Time courses of specific binding of [3H]PG~ to gland membranes. 
Binding assays were performed in triplicate at the indicated temperatures for the indicated 
times using 3 nM [3H]PG:Ei and 50 µg of membrane protein (the assays used pH 8.5 and 
300 mM MgC12). (a) time courses ofdisplacement of Specific [3H]PGE2 binding to 
gland membranes. The binding assays were performed in triplicate at 37°C using 3 nM 
PHJPGE2 and 50 µg of membrane protein. Values represent the mean of triplicate 
determinations ± SE. 
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Figure 3.9 (A) Effects of purine nucleotides on specific binding of [3H]PG:Ei to gland 
membranes. Purified membranes were prepared and binding assays were performed in 
triplicate using 3 nM [3H]PG:Ei and 50 µg of membrane protein in the presence or absence 
of 1 mM or 5 mM (#) various purine nqcleotides at 30°C for 4 hr (the assays used pH 
8.5 and 300 mM MgC}i). Values represent the meanoftriplicate determinations± SE. *: 
Significantly different from control (no purine nucleotide) (P <0.05). (B) Inhibition of 
specific [3H]PG:Ei binding to gland membranes by I mM GTPyS. Membrane 
preparations and binding assays were performed as in (A). Values represent the mean of 
triplicate determinations ± SE. 
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SIGNAL TRANSDUCTION OF THE PROSTAGLANDIN E2 
RECEPTOR IN TICK SALIVARY GLANDS 
INTRODUCTION 
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External signals (e.g. hormones, neurotransmitters) bind to plasma membrane receptors on 
cell surfaces and are transduced and amplified into "second messenger" molecules and ions 
within the cell which thus change cellular activities. Various signal transduction pathways 
have been described for PGE receptors in mammalian tissues, e.g. pathways that cause an 
increase in intracellular Ca2+ and pathways which increase or decrease intracellular cyclic 
AMP (cAMP) (Narumiya, 1995). An increase in intracellular Ca2+ is induced by either or 
both of two mechanisms, one caused by Ca2+ entry from the outside and the other by 
mobilization of intracellular Ca2+. Calcium and cyclic AMP appear to be important in 
controlling fluid secretion in tick salivary glands (Sauer and Hair, 1986). Deletion of 
calcium or the addition of the calcium channel antagonist verapamil to the bathing medium 
inhibits dopamine-stimulated fluid secretion by isolated salivary glands, implicating an 
external source ofCa2+ in maintaining secretion (Needham and Sauer, 1979). A "second 
messenger" role for cAMP is indicated in that exogenous cAMP stimulates fluid secretion 
in isolated salivary gland preparations (Sauer et al., 1979). Furthermore, changing 
activities of adenylate cyclase and cAMP-dependent phosphodiesterase during tick feeding 
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are found to correlate with an increase in the rate of salivary fluid secretion as the tick 
progresses from the slow to rapid stage of feeding (Sauer et al., 1979). Thus, regulation 
of the enzymes that regulate levels of cAMP is an important mechanism for regulating the 
magnitude of fluid secretion in salivary glands of feeding ixodid females (Sauer and 
Essenberg, 1984). The increase in salivary gland cAMP occurs when dopamine released 
from a salivary nerve interacts with a D1-like, G protein-coupled receptor, which results in 
the activation of an adenylate cyclase and stimulates formation of cAMP (Sauer et al., 
1995). 
Prostaglandins of the 2-series (e.g. PGE2) are typically synthesized from arachidonic acid 
(AA) after AA is released from cellular phospholipids following activation of an 
intracellular phospholipase A2 (PLA2). Dopamine stimulates release of AA from salivary 
gland phospholipids presumably by activating an intracellular PLA2 (Bowman et al., 
1995a). Treatment of isolated salivary glands with PLA2 inhibitor oleyloxyethyl 
phosphorylcholine (OPC) or prostaglandin synthetase inhibitors reduces dopamine-
induced fluid secretion and cAMP levels in isolated salivary glands. PGE2 or its analog 17-
phenyl trinor PGE2 partially reverses inhibition of secretion and cAMP level by OPC, 
suggesting that prostaglandins produced following gland stimulation by dopamine may 
have an autocrine effect in modulating salivary gland function (Chapter 2). Furthermore, a 
specific PGE2 receptor coupled to a cholera toxin-sensitive G protein has been identified 
in the plasma membrane fraction of the salivary glands (Chapter 3). The following 
experiments were designed to determine if "second messengers" are mobilized in salivary 
gland cells after PGE2 binds to its specific receptor. The possibility of an effect on 
adenylate cyclase activity or an effect on an increase in intracellular Ca2+ were examined. 
MATERIALS AND METHODS 
Materials 
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Reagents were obtained from the following sources: Dowex 50W-H+ cation exchange 
resin (200-400 mesh, 8% cross-linkage), neutral alumina (type WN-3), ATP, cyclic AMP, 
creatine phosphate, creatine phosphokinase, dithiothreitol, bromo-A23187, prostaglandin 
E2, indomethacin, trichloroacetic acid (TCA), trioctylamine, 1, l ,2-trichloro-1,2,2-
trifluoroethane (TCTFE), and other chemicals were acquired from Sigma Chemical 
Company, St.Louis, MO. [a32P]ATP(3000 Ci/mmol), [2,8-3H]cAMP (30 Ci/rnrnol), 
45CaCh (40.58 mCi/mg) and the inositol-1,4,5-trisphosphate [3H]radioreceptor assay kit 
were from Du Pont New England Nuclear (Boston, MA). ScintiSafe™ Econo2 was 
obtained from Fisher Scientific (St. Louis, MO). Silicone fluids 556 (0.98 g/ml) and 550 
(1.07g/ml) were gifts from Dow Corning Corporation (Midland, MI). 
Preparation of Dispersed Salivary Glands 
Glands from 20 ticks were dissected and placed in 1 ml of culture medium L- l 5B (Sigma 
catalogue#, L4386) at pH 7.8, containing 1 rnM indomethacin, 100 units of penicillin and 
100 µg streptomycin. The salivary glands were then dispersed mechanically 
(Ramachandra, personal communication) using two Clay Adams slides (Fisher catalogue#, 
3051) which have one end frosted on one side of each slide. The resulting suspension was 
confirmed for gland dispersion under a 200x microscope (BHS Olympus, Olympus 
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Optical Co. Ltd., Tokyo, Japan). The viability of the dispersed acini and cells was 
examined using trypan blue stain and at least 60% of the cells maintained viability after the 
treatment. The suspension of the dispersed acini and cells was centrifuged at 325g for 4 
min. The pellet was washed twice using the medium L-15B and resuspended in the 
medium L-15B for use in the assays for the formation ofIP3, 45Ca2+ influx and efflux. 
Assay for Adenylate Cyclase Activity 
Adenylate cyclase activity was measured as described by Schmidt et al. (1982) and 
Farndale et al. (1992) with some modifications. The principle ofthis method is use of 
[a32P]ATP to generate [a32P]cAMP followed by a simple two-column chromatography 
system to separate labeled cAMP from other labeled adenine nucleotides (Farndale et al., 
1992). The basic assay mixture contained 25 mM Tris-HCl, pH 7.5, 100 µM[a32P]ATP 
(106 cpm), 5 mM MgCb, 0.77 mM IBMX, 0.1 mM EDTA, 500 µM cAMP, 20 mM 
creatine phosphate, 50 units/ml creatine kinase, 1 mM dithiothreitol. Assays were initiated 
by the additions of PGE2 and gland membranes (40 µg protein). Reactions were allowed 
to proceed at 3 7°C in a water bath for 15min and were stopped by adding a solution 
containing 2% SDS, 40 mM ATP and 1.4 mM cAMP in deionized water. cAMP was 
separated from other adenine nucleotides in two steps using Dowex 50 cation exchange 
and neutral alumina columns. Columns with a total volumn of 10 ml supplied by Bio-Rad 
(Catalogue#, 731-1150) were used but the plastic sinter supplied was replaced with glass 
wool to give a satisfactory flow rate. The Dowex column rack was located on top of the 
alumina column rack so that the Dowex columns drip into the tops of the alumina 
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columns. The alumina columns in tum drip into scintillation vials. Dowex columns were 
prepared by pipetting 2 ml of a stirred slurry of 50% Dowex 50x4 200 in 1 M HCl into 
columns which gave a bed volumn of 1 ml. The Dowex columns were regenerated by 
washing with 3 ml of 1 M HCl. Alumina columns were prepared by placing 0.8 g of 
alumina into each column and primed with 10 ml of 0.3M imidazole buffer. Each sample 
was transferred to Dowex columns primed with 15 ml deionized water and washed with 1 
ml of deionized water twice. The Dowex columns were then located on top of the alumina 
columns and the cAMP was eluted from the Dowex columns onto the alumina columns 
with 6 ml of deionized water. The alumina columns were washed once with 1 ml of 0.3M 
imidazole buffer and the cAMP was finally washed from the alumina columns with 1.75 ml 
of 0.3M imidazole buffer. The eluates were collected in scintillation vials and quantitated 
by liquid scintillation counting using the scintillant ScintiSafe™Econo 2. Tracer amounts 
of [3H]cAMP were added to monitor the recovery of biosynthetic [ a 32P] cAMP that was 
isolated by sequential chromatography of the samples on Dowex 50W-X4 and alumina 
columns (Famdale et al., 1992). cAMP recoveries were 70-80% using this isolation 
procedure. The [32P]cAMP generated during the assay was calculated as picomoles cAMP 
per milligram membrane protein by the following formula: 
(sample 32P c.p.m.) x (3H cAMP recovery standard c.p.m.) 
assay constant x (sample 3H c.p.m.-(sample 32P c.p.m. x spillover)) 
where the assay constant was defined as the value for multiplying specific activity of 
[a32P]ATP by the milligrams of membrane protein in the assay. Adenylate cyclase activity 
was then obtained by dividing this figure by the assay time. 
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Assay for the Formation oflP3 
Dispersed salivary glands were suspended in 20 mM morpholinopropane sulfonic acid 
(MOPS) buffer at pH 7.5, containing 177 mM NaCl, 15 mM KHC03, 3.5 mM CaCh, 2.8 
mM MgS04, 32 mM glucose, 0.1 g/1 bovine serum albumin (BSA), 0.03 g/1 penicillin and 
0.1 g/1 streptomycin sulfate (McSwain et al., 1989). Assays were initiated by the addition 
of PGE2 or its solvent carrier, 10 mM LiCl (a myo-inositol 1-phosphatase inhibitor) and 1 
mM indomethacin in 20 mM MOPS buffer. Reactions were allowed to proceed at 37°C 
for 30 seconds, and stopped and IP3 was extracted with 0.2 volumes ofice-cold 
100% TCA solution and vortexed thoroughly. TCA was then removed from extracts with 
a 3:1 (v/v) solution ofTCTFE-trioctylamine. After extraction, the aqueous phase 
containing IP3 was removed and stored on ice until assayed for level oflP3. 
The radioreceptor asssay kit consists of membranes derived from calf cerebellum 
containing the IP3 receptor. The receptor binds IP3 and [3H]IP3 competitively. The amount 
of [3H]IP3 bound to the receptor was measured after centrifuging the membranes and 
counting bound radioactivity in the pellet by liquid scintillation counting using the 
scintillant ScintiSafe™Econo 2. Unlabeled IP3, added to the incubation mixture as either 
known amounts of standard or the unknown sample, competed with [3H]IP3 for binding to 
the receptor. Non-specific binding caused by tracer which was not bound to the receptor 
but which remained attached to other parts of the membrane or the tube was determined 
by saturating the receptor with a large amount of cold inositol hexaphosphate (IP6) (IP6 
produces the same non-specific binding as high concentrations oflP3). The concentration 
of each sample was determined by interpolation from a standard curve derived by using 
known amounts ofIP3. 
The 45Ca2+ -Release Assay 
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Measurement of 45Ca2+ eftlux was based on the method described by Wilcox et al. (1995) 
with some modifications. The principle involves preloading 45Ca2+ into intracellular stores 
and then monitoring release of 45Ca2+ induced by an agonist. Eftlux from preloaded tissue 
is a function of the free cytosolic ion level available for transport. The dispersed salivary 
. glands were suspended in a buffer whose fivefold stock contained 120 mM KCl, 2 mM 
KH2P04, 5 mM (CH2COONa)2, 2 mM MgCh, and 20 mM HEPES-free acid. Since ATP 
is relatively unstable in alkaline solutions, it was added to the final buffer just prior to use. 
The fivefold stock buffer (1 vol) was added to a container with preweighed Na2ATP (2 
mM final), diluted to 5 vol with H20, and the pH corrected to 7.2 using 20% (w/v) KOH. 
4 µM EGTA was added to this buffer to chelate contaminating Ca2+. The dispersed glands 
were suspended in the final buffer, and 1 µ1 of oligomycin ( 5 mg/ml ethanol) and 10 µCi of 
45Ca2+ in 2 ml of incubation medium. Oligomycin was used to exclude Ca2+ uptake into the 
mitochondrial pool. The mixture was quickly vortexed and placed in a 3 7°C water bath for 
30 min for 45Ca2+ loading. The mixture was then centrifuged at 325 g for 4 min and the 
pellet was washed twice to remove unincorporated isotope and resuspended in the final 
buffer. 50 µ1 of PGE2 or its solvent carrier was added to each 50 µ1 of the suspension, 
followed by incubation at 37°C for 30 seconds. The reaction was stopped by adding 400 
µ1 of silicon oil mixture (silicone fluids 556 and 555 in 3 :2, v/v) to separate the aqueous 
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phase from cell pellet. The cells were centrifuged through the oil at 12000 g for 5 min. 
The aqueous phase and most of the silicon oil were carefully removed to avoid disturbing 
the cell pellet or "smear" on the opposite side of the tube. The tubes were inverted on 
adsorbent paper underlayered with aluminum foil for at least 1 hour to remove the oil. 
Finally, the cell pellet was solubilized in 50 µl of 0.15 N NaOH and radioactivity of the 
retained 45Ca2+ was measured by liquid scintillation counting using the scintillant 
ScintiSafe™Econo 2. The percentage release of 45Ca2+ was expressed as: 
% 45Ca2+-release = (T-Y) IT xlOO 
where T was the total radioactivity in the cells before the addition of agonist, and Y was 
radioactivity retained in the cells at the end of incubation with agonist. The calcium 
ionophore bromo-A23187 (20 µM final) was used as an internal control to define the total 
mobilizable cellular Ca2+ pools in the 45Ca2+ -preloaded cells. 
Assay of 45Ca2+ influx 
The experiments were performed as described by Tokuda et al.(1994) with some 
modifications. The dispersed salivary glands were suspended in a buffer containing 140 
mM NaCl, 1 mM MgCh, 5 mM KCl, 1.5 mM CaCh, 10 mM HEPES, Tris (pH 7.4), 5 
mM glucose, 0.1 % bovine serum albumin (BSA) and preincubated at 37°C for 10 min. 
200 µl of the cell suspension was then stimulated by 10"5M PGE2 in the same buffer 
containing 1 µCi of 45Ca2+ at various time intervals. After washing three times with 1 ml of 
the same ice-cold assay buffer without CaCh and 0.1 % BSA, cell pellets were solubilized 
in 50 µ1 of 0.15 N NaOH, and the cell-associated radioactivity was measured by liquid 
scintillation counting using the scintillant ScintiSafe™Econo 2. 
Statistical Analysis 
The differences between the control and experimental treatment were tested for 
significance by Student's t test. AP value <0.05 was considered significant. 
RESULTS 
Adenylate Cyclase Activity 
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Since PGE2 and its analog 17-phenyl trinor PGE2 were shown to affect intracellular cAMP 
formation and the PGE2 receptor is coupled to a cholera toxin-sensitive G protein which is 
often linked to activation of adenylate cyclase, I tested whether PGE2 had a direct effect 
on adenylate cyclase activity in the tick salivary glands. Although PGE2 affects cAMP 
concentrations in whole salivary glands, various concentrations of PGE2 (10-9 M-10-5 M) 
had no effect on plasma membrane adenylate cyclase activity (Table 4.1). High adenylate 
cyclase activity was observed with dopamine, thus, demonstrating that the assay system 
was valid. 
Effect of PGE2 on the Formation of inositol 1,4,5-trisphosphate (IP3} 
Thirty seconds of stimulation by PGE2 increased the amount of IP3 in dispersed salivary 
glands in a dose-dependent manner (Fig. 4.1). The maximum effect of PGE2 occurred at 
10 µM. The result suggests that PGE2 activates a phospholipase C (PLC) and causes the 
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hydrolysis of phosphatidylinositol 4,5-bisphosphate in tick salivary glands after binding to 
its receptor. 
Effect of PGE2 on 45Ca2+ -Release 
IP3 is known to mobilize calcium from intracellular stores in a variety of cell types 
(Berridge, 1993). Since the previous results indicated that PGE2 stimulated the formation 
of intracellular IP3, I examined the ability ofPGE2to stimulate release of intracellular 
45Ca2+ from pre-labelled salivary glands. PGE2 increased 45Ca2+ release from the 45Ca2+ -
preloaded cells in comparison to control cells stimulated by the solvent carrier (Fig. 4.2). 
Effect of PGE2 on the 45Ca2+Influx 
In order to see if PGE2 increases an influx of calcium, the dispersed salivary gland cells 
were exposed to PGE2 (10-5 M) for different times at 37°C. The result showed that PGE2 
did not stimulate 45Ca2+ influx during an extended time period (Fig. 4.3). In contrast, PGE2 
decreased 45Ca2+ uptake by the salivary glands as compared to the control (solvent carrier 
of PGE2 solution). 
DISCUSSION 
Although PGE2 has been shown to increase dopamine-stimulated cAMP formation, results 
indicate that PGE2 does not directly activate salivary gland adenylate cyclase. The reason 
for this apparent inconsistency is unclear, but it could be due to an effect of mobilized Ca2+ 
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on adenylate cyclase activity, since Ca2+ is known to affect adenylate cyclase in many cells 
(Tsunoda, 1993). 
PGE2 was shown to stimulate lP3 formation in tick salivary glands. Cells produce lP3 after 
activation of a specific phosphatidylinositol 4,5-bisphosphate phospholipase C (PLC). In 
some cases, receptors are coupled through G proteins to stimulate phospholipase C-~ 
(PLC-~), whereas in other cells tyrosine kinase-linked receptors are specifically coupled to 
PLC-y. These receptors activate PLC to hydrolyse phosphatidylinositol 4, 5-bisphosphate 
(PIP2), located in the inner leaflet of the plasma membrane, to yield both IP3 and 
diacylglycerol (DAG), which function as second messengers (Berridge, 1993). The 
pathway oflP3 formation in tick salivary glands appears to be through PLC-~ since the 
PGE2 receptor is coupled to a G protein. lP3 was proposed as a second messenger more 
than one decade ago (Streb et al., 1983). It is now clear that lP3 released into the cytosol 
mobilizes calcium from internal stores, particularly the endoplasmic reticulum, by binding 
to a specific receptor (Berridge, 1993). IP3-stimulated release of calcium controls a variety 
of cellular processes including secretion, metabolism, phototransduction, and cell 
proliferation (Berridge and Irvine, 1984). A phosphoinositide signaling pathway activated 
by a peptide from the tick synganglion is known to exist in tick salivary glands (Mcswain 
et al., 1989). The effects oflP3 on intracellular Ca2+ mobilization in permeabilizied tick 
salivary glands has been observed (Roddy et al., 1990). The effect ofPGE2 on lP3 
formation indicates that lP3-calcium signalling pathway occurs in response to activation of 
PGE2 receptors in tick salivary glands. The result is consistent with the previous findings 
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of the effectiveness of 17-phenyl trinor PGE2 on fluid secretion. 17-phenyl trinor PGE2 is a 
potent and selective agonist for PGE2 receptor subtype EPl in mammals (Johnson et al., 
1980). Stimulation ofEPl by PGE2 induces an increase in intracellular Ca2+ concentration 
in mammalian cells (Narumiya, 1996). 
Other experiments were performed to examine if a correlation exists between stimulation 
of salivary gland cells by PGE2 and an increase in cytosolic Ca2+ concentration. An 
increase in cytosolic Ca2+ concentration could occur via two mechanisms: release from 
intracellular stores and entry across the plasma membrane through Ca2+ channels. I tested 
the effects of PGE2 on both of these possibilities. 45Ca2+ influx assays demonstrate that 
PGE2 does not stimulate an influx of external calcium into salivary gland cells. However, 
PGE2 does increase 45Ca2+ release from 45Ca2+ preloaded salivary gland cells, further 
demonstrating that the signal transduction for the PGE2 receptor in tick salivary gland 
includes activation of a phosphatidylinositol 4,5-bisphosphate PLC, increase in cytosolic 
lP3 and mobilization of intracellular Ca2+. 
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Table 4.1 Comparison of the effects ofPGEi and dopamine on adenylate cyclase in 
salivary gland membranes. The data are means determined from three assays. * indicates 
significantly different from basal level of adenylate cyclase activity (P <0.05). Basal level 
of adenylate cyclase activity was 197 ptnoles/mg/min for measuring the effect of PGE2 
and 112 pmoles/mg/min for measuring the effect of dopamine. 
Treatment Concentration (M) % of basal activity 
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Figure 4.1 Effect of PG~ on IP3 formation in dispersed salivary glands that were 
prepared from partially fed Amblyomma americanu,n (L.) females as described in the text. 
The suspensions were then stimulated for 30 seconds at 37°C with the indicated 
concentrations of PG~, and IP3 was det~rmined by using an IP3 [3H] radioreceptor assay 
kit. The values represent the mean of four determinations ± SD. *: significantly different 
from control (no PG~) (P<0.05). 
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Figure4.2 Effect ofPGEi on 45Ca2+-release in dispersed salivary glands measured 
after 30 sec exposure to the indicated agonists. Data are expressed as the mean ± SD of 
three determinations, each performed in duplicate. *: significantly different from the 
control (no PGE2) (P<0.05). 
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Figure 4.3 Effect ofPGEi.on the uptake of45Ca2+ in dispersed salivary glands. Cells 
were treated with I 0-5M PGEi (Exp: •) or the solvent carrier (Control: o) for the indicated 
time periods and the cell-associated 45Ca2+ was measured. The values are calculated as 
percent of the uptake of 45Ca2+ of control cells at 18 min; Each point gives the mean ± SD 













Tick salivary secretion is controlled by the action of the neurotransmitter dopamine 
through the classic second messenger, cAMP. Dopamine released from a salivary nerve 
exerts its control via the action of a G protein-coupled receptor (Dl dopamine receptor), 
which results in the activation of an adenylate cyclase and the formation of cAMP (Sauer 
et al., 1995). The increased cAMP then leads to augmented fluid secretion of the salivary 
glands (Needham and Sauer, 1979). Other data indicate that dopamine stimulates release 
of arachidonic acid presumably by activating an intracellular phospholipase A2 (PLA2) 
(Bowman et al., 1995a). My data provides evidence that the arachidonic acid metabolite 
PGE2 plays a role in modulating dopamine-induced fluid secretion in tick salivary glands. 
Inhibitors of prostaglandin synthesis reduce dopamine-stimulated secretion and exogenous 
PGE2 significantly enhances dopamine-induced secretion inhibited by an inhibitor of PLA2 
(OPC). The cellular mechanisms by which PGE2 enhances dopamine-stimulated fluid 
secretion have been examined in biochemical studies measuring cAMP generation in 
isolated salivary glands. PGE2 increases cAMP accumulation in the isolated salivary glands 
after dopamine-stimulated accumulation is inhibited by OPC. Furthermore, a high affinity, 
cholera toxin-sensitive PGE2 receptor has been identified in tick salivary glands, 
suggesting that PGE2 exerts its effects by interacting with its specific G protein-linked 
receptor on plasma membranes in tick salivary glands. However, PGE2 does not affect 
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adenylate cyclase directly but rather increases inositol trisphosphate (IP3) production, 
presumably by stimulating phosphatidylinositol hydrolysis. Since diacylglycerol is formed 
together with inositol phosphates via this signal transduction pathway (Nishizuka, 1984; 
Berridge, 1987), one would expect that protein kinase-C is also activated when PGE2 
binds to its receptor. Diacylglycerol and Ca2+ together are known to activate protein 
kinase C in cells (Nishizuka, 1988). IP3 stimulates Ca2+ mobilization from the intracellular 
stores and thus raises the levels of intracellular Ca2+. The increased intracellular Ca2+ may 
contribute to modulating cAMP levels induced by dopamine through its effect on 
adenylate cyclase (Tsunoda, 1993). Thus, it is conceivable that PGE2 functions in a 
positive feedback manner, whereby PGE2 raises intracellular Ca2+ and stimulates 
dopamine-induced fluid secretion. Other functions for increased levels of Ca2+ such as 
exocytosis seem possible. A model for the action of PGE2 in modulating tick salivary 
secretion based on these statements is thus advanced (Fig. 5.1). 
Now that the properties of PGE2 receptor have been mapped out biochemically, future 
attention should focus on molecular biology of the receptor and other possible functions 
for increases in cellular Ca2+. Cloning of the PGE2 receptor and elucidating its molecular 
structures appear to be feasible given that sequences of prostaglandin receptor genes are 
known in mammals and the effectiveness of 17-phenyl trinor PGE2 in mimicking the 
physiological effects of PGE2 in tick salivary glands. 17-phenyl trinor PGE2 is thought to 
be very specific for the Ca2+ mobilizing PGE2 EPl receptor in mammals (Negishi et al., 
1993), being consistent with the ability of PGE2 to mobilize Ca2+ in tick salivary glands. 
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Molecular data would enable us to identify the tissue and cell distribution of the receptor's 
expression. Cellular localization of PGE2 receptors would help discover new functions for 
PGE2 in overall tick salivary gland physiology. 
Figure 5.1 Model for the action of PGE2 in modulating tick salivary secretion. 
Abbreviations include: DA, dopamine; DI, dopamine receptor subtype; G, G-protein; 
AC, adenylate cyclase; PK, protein kinase; Protein-P, phosphorylated protein; R, 
prostaglandin E2 receptor; PLA2, phospholipase A2; AA, arachidonic acid; PGEz, 
prostaglandin E2. PIP2, phosphatidylinositol 4,5-bisphosphate; PLC, phospholipase C; 
IP3, inositol 1,4,5-trisphosphate. Dash line and "?" indicate uncertainty. 
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